CLBT

CLBT

USD

Cellebrite DI Ltd. Ordinary Shares

$16.240-0.010 (-0.062%)

Reaalajas hind

Tehnoloogia
Software - Infrastructure
Iisrael

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$16.250

Kõrge

$16.305

Madal

$15.895

Maht

1.34M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

3.9B

Tööstusharu

Software - Infrastructure

Riik

Israel

Kauplemisstatistika

Keskmine maht

1.24M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $11.47Praegune $16.240Kõrge $26.3

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 23. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

CLBT (Cellebrite DI Ltd. Ordinary Shares): Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLBT Generate Date: 2025-05-23 02:01:22

Let's break down what's been happening with Cellebrite's stock lately and what the signals might be suggesting. Think of this as looking under the hood to see what's driving things.

Recent News Buzz: What's the Vibe?

Looking at the latest headlines, the feeling around Cellebrite is a bit mixed, but leans positive in terms of company activity and sentiment.

  • First off, the company is getting out there, announcing they'll be at upcoming investor conferences. That's pretty standard stuff, showing they're engaging with the financial community. It's generally seen as a neutral to slightly positive sign.
  • Then there's news about a new product release – their "Spring 2025 Release." Companies putting out new stuff is usually good news, especially for a tech firm like Cellebrite which is all about digital investigation solutions. It suggests innovation and trying to stay ahead.
  • However, we also saw an analyst from Needham maintain their "Buy" rating on the stock, which sounds great, but they actually lowered their price target from $28 down to $24. So, while they still think it's a stock to buy, they see less potential upside than before. That's a bit of a dampener.

Putting it together, the news shows the company is active and innovating, which is positive. An analyst still likes the stock enough to recommend buying, but the lowered target is a yellow flag. Interestingly, the AI analysis of recent news sentiment comes back as "highly positive," suggesting the overall feeling from the news flow is upbeat despite that lowered price target.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock price itself over the last few months.

Back in late February and March, the stock was mostly trading in the $18-$19 range, sometimes pushing above $20 in late March and early April. It had a decent run there for a bit.

But then, around the middle of May (right when that analyst note came out, actually), the price took a pretty sharp dive. It dropped from around $20 down into the $17 range quite quickly. Since that drop, it's been trading mostly sideways, bouncing between roughly $16.70 and $17.50. The last recorded price was around $16.71.

So, the recent trend is clearly down from its April highs, followed by a period of trying to find its footing at a lower level.

Now, here's where it gets interesting: the AI prediction for the next few days is quite bullish. It forecasts price increases of around 1.45% today, 2.86% tomorrow, and 3.96% the day after. This suggests the AI sees potential for a bounce or a short-term upward move from these current lower prices.

Outlook & Ideas: Putting It All Together

Okay, so we have a mix of signals: positive company news (product, investor engagement), mixed analyst view (Buy but lower target), a recent sharp price drop, and a bullish short-term AI prediction.

Based on this specific data, the apparent near-term leaning seems to be cautiously positive, primarily driven by the strong AI prediction for the next few days and the positive news sentiment score, despite the recent price weakness and the analyst's lowered target. The AI seems to think the recent dip might be a temporary thing and sees room for a bounce.

  • Potential Entry Consideration: If you were looking at this stock and found the AI's bullish short-term outlook compelling, the current price area (around $16.70) or slightly higher (like the $17.11-$17.20 range mentioned in the recommendation data) could be considered as potential entry points. Why? Because it's right where the stock has been trading recently after the dip, and the AI predicts it will go up from here. The recommendation data also points to $17.08 as a potential support level, which is right in this neighborhood.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key.
    • For taking profits, the recommendation data suggests a very near-term target of $17.38. This is close to the recent trading range high and could be a target for a quick bounce trade. Looking further out, the analyst's lowered target is $24, and the AI's projected target is $24.54. These are much higher and would require a significant, sustained upward move, but they give an idea of potential upside if the trend really reverses.
    • For cutting losses (a stop-loss), the recommendation data suggests $15.33. This level is below the recent lows seen during the May 14th drop. If the stock falls below this point, it might signal that the recent weakness is continuing, and the bullish AI prediction isn't playing out.

Company Context

Just a quick reminder about Cellebrite: they are a tech company focused on digital investigation tools. They help law enforcement and companies access and analyze digital data for legal cases. This means their business can be influenced by government spending, cybersecurity trends, and the need for digital evidence in investigations. The new product release fits right into this core business.

Remember, this analysis is based only on the provided data points – the news, the recent price history, and the AI predictions/recommendations.


Disclaimer: This report is for informational purposes only and is based on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

Analyst Upgrades

Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target

Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $24 price target.

Vaata rohkem
Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target
GlobeNewswire

Cellebrite to Acquire Corellium

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its

Vaata rohkem
Cellebrite to Acquire Corellium
GlobeNewswire

Cellebrite Announces Participation in Upcoming Investor Conferences

TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that

Vaata rohkem
Cellebrite Announces Participation in Upcoming Investor Conferences

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 13. juuni 2025, 01:38

LangevNeutraalneTõusev

69.6% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Kasv
Kauplemisjuhend

Sisenemispunkt

$16.22

Võta kasum

$16.56

Peata kahjum

$14.62

Põhitegurid

PDI 6.7 on MDI 4.7 kohal ADX-iga 25.5, mis viitab tõusutrendile
Praegune hind on tugitasemele ($16.18) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 8.5x keskmisest (15,355), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0342 on signaalijoone 0.0349 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.